期刊
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
卷 47, 期 8, 页码 950-954出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PAS.0000000000002069
关键词
ALK; large B-cell lymphoma; PABPC1
ALK-positive large B-cell lymphoma (LBCL) is a rare and aggressive type of LBCL with poor prognosis. This case report highlights a unique expression of epithelial-associated markers and a novel PABPC1::ALK fusion gene in ALK-positive LBCL. It also emphasizes the importance of comprehensive immunophenotyping to avoid misdiagnosis and contributes to the understanding of this uncommon lymphoma.
Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma (LBCL) is a very rare type of LBCL with an aggressive clinical course and poor prognosis. This diagnosis can be challenging given the varied morphology (immunoblastic, plasmablastic, or anaplastic), frequent lack of B-cell antigens, and especially in cases with expression of epithelial antigens. Here, we report a case of ALK-positive LBCL with unusual expression of 4 epithelial-associated markers (AE1/AE3, CK8/18, EMA, and GATA3) and novel poly(A) binding protein cytoplasmic 1 (PABPC1)::ALK fusion which has not been previously reported in this entity. This case also emphasizes the use of comprehensive immunophenotyping that includes multiple lineage-specific antibodies when faced with a malignancy without a clear differentiation to avoid misdiagnosis. This case only achieved partial response to combination chemotherapy, radiation, and ALK inhibitor regimens, and furthers our understanding of this uncommon lymphoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据